The beneficial effects of cardiac resynchronization therapy (CRT) have been well established in large, randomized trials.
C ardiac resynchronization therapy (CRT) has effectively had an impact on the natural trajectory of symptomatic heart failure (HF) in patients with coexisting conduction tissue disease.
CRT brings its physiological impact to bear through synchronizing cardiac contraction, resulting in favorable ventricular remodeling and improvement in ejection fraction (EF). Prospective randomized studies of patients with both ischemic and nonischemic causes of HF have shown that this effect of CRT translates into long-term clinical benefits, such as improved quality of life, increased functional capacity, reduction in hospitalization for HF, and overall mortality (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . Despite the success of this therapeutic modality, a significant proportion of patients may not respond sufficiently or in a predictable way to this pacing therapy. There are several determinants of successful response to CRT; QRS duration and QRS morphology are of considerable importance in this response.
Although surface electrocardiographic (ECG) evidence of electrical dyssynchrony due to the presence of an intraventricular conduction delay (IVCD) serves as a surrogate for ventricular mechanical dyssynchrony, its precision in predicting response may be limited by the complexity of electrical and mechanical dyssynchrony in the diseased heart. Dyssynchrony can exist at numerous levels within the heart: within the atria; between the atrium and ventricles; and at different levels within the ventricles (i.e., at the interventricular, intraventricular, and intramural levels) (12, 13) . These factors may operate to greater or lesser degrees in an individual patient, such that a simple approach based on the ECG markers (QRS morphology and QRS duration) may not adequately represent the conduction patterns within any single heart. Nevertheless, these ECG surrogates of electromechanical dyssynchrony are the clinical tools on which we rely to help select patients for CRT. This review focuses on dyssynchrony within the ventricle, the electrical conduction abnormalities that underlie mechanical dyssynchrony, and the clinical trial data defining appropriate patient selection for CRT.
MECHANICS OF ELECTRICAL ACTIVATION
As discussed in detail later, there is a large amount of The patterns of activation in the myopathic heart can affect patients manifesting an RBBB pattern.
Electroanatomic mapping of such patients has found significant LV conduction delay (especially in very prolonged QRS duration), albeit with wide variability in the degree of mechanical dyssynchrony. There is evidence that in some patients, the presence of an RBBB ECG pattern may mask a coexistent LBBB as an explanation for this finding. This situation may be recognized by the concomitant presence of broad, slurred, and occasionally notched R waves in leads I and aVL, along with left-axis deviation (23) (24) (25) (26) (27) .
Several other proposed explanations for a worse outcome in patients with RBBB include: 1) ventricular dyssynchrony patterns, which are simply not favorable for CRT; 2) concomitant right ventricular dysfunction; and 3) more extensive conduction disease (28).
As will be discussed further, QRS morphology is simply 1 determinant of CRT response. Although areas of delayed activation result in mechanical dyssynchrony, the duration of activation delay also seems to be a critical component. Table 1 .
Whereas the required minimum enrollment QRS interval varied between 120 and 200 ms in these trials, the median QRS duration centered around 150 ms (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . Most of the more recent and larger trials reported on the interaction of QRS duration and the primary endpoint ( Table 2) Resynchronization Therapy for Heart Failure) trial CRT for the primary endpoint of an increase in peak oxygen consumption >1.0 ml/kg during cardiopulmonary exercise testing at 6 months (34).
In IVCD, leaving few patients with an RBBB available to draw any conclusion regarding CRT benefit ( Table 1) .
Given that limitation, however, the data that are available are consistent: patients with an RBBB have demonstrated little or no benefit from CRT therapy.
These observations have led to a specific emphasis on 
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follow-up (7 years), the benefit continued to be confined to those with LBBB QRS morphology for the outcomes of cumulative probability of all-cause mortality (adjusted p < 0.001) and nonfatal HF events (adjusted p < 0.001). A concerning observation was the trend toward an increased risk of death observed for those with a non-LBBB QRS morphology when a
Cox proportional hazards regression analysis was performed. QRS duration had no effect on these findings (QRS $150 ms or <150 ms), nor did having IVCD versus RBBB QRS morphology (21) . Tables 1 and 2 .
Poole et al. However, the practical reality of performing CRT is that finding the "ideal" LV lead-pacing site is often simply limited by coronary sinus venous anatomy.
There may not be an acceptable vein in the desired position, whether directed by QRS morphology, electrical activation delay, or by use of advanced imaging techniques.
PUTTING IT ALL TOGETHER
There are a number of critical factors that must be taken into account for CRT to be effective. These include confirmation that: 1) mechanical dyssynchrony is actually present; 2) conduction is sufficiently delayed; 3) the area of late activation can be identified; 4) comorbid conditions are considered; 5) myocardial scarring, possibly altering conduction pattern, is recognized; 6) sex-specific responses may be operative; and 7) placement of the pacing lead Figure 1 .
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ideally targets the area of late activation. Ultimately, the goal is to achieve reversal of electromechanical dyssynchrony. Although a QRS interval >120 ms is a reasonable starting point for patient selection, those most likely to benefit are patients with an LBBB and delayed activation of the LV lateral myocardium.
In patients with a non-LBBB morphology, a more individualized approach may be required when considering patients with a less than "ideal" ECG profile ( Figure 2) . Recent data from MADIT-CRT also suggests that a subgroup of non-LBBB patients with a prolonged PR interval derived benefit from CRT compared with patients with a normal PR interval and non-LBBB. Therefore, this ECG finding should also be taken into account when considering non-LBBB patients for CRT (60) . 
